Dergiler / Turkish Medical Student Journal / 2020 / Cilt: 7 - Sayı: 3

PATHOPHYSIOLOGY, CLINICAL FEATURES AND TREATMENT OF MICROVASCULAR ANGINA: A REVIEW

Sayfa
154–158
Yayın Tarihi
2020-10-31
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

It is essential for every medical practitioner to recognize a patient with microvascular angina, as the disease has some characteristic presentations, does not respond well to the classical treatments for angina pectoris, and eventually may result in serious complications later.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Microvascular angina is a non-obstructive coronary syndrome which presents itself as anginal chest pain with different features compared to other causes of angina pectoris.
📊
Temel Bulgular & Veri:Although, it occurs through a similar mechanism with the better-understood variant (prinzmetal) angina, unlike the former, microvascular angina affects the subendocardial thin, therefore less compliant vessels.
💡
Sonuç & Katkı:It is essential for every medical practitioner to recognize a patient with microvascular angina, as the disease has some characteristic presentations, does not respond well to the classical treatments for angina pectoris, and eventually may result in serious complications later.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Microvascular angina · coronary syndrome · angina pectoris

Abstract

Microvascular angina is a non-obstructive coronary syndrome which presents itself as anginal chest pain with different features compared to other causes of angina pectoris. Although, it occurs through a similar mechanism with the better-understood variant (prinzmetal) angina, unlike the former, microvascular angina affects the subendocardial thin, therefore less compliant vessels. It is essential for every medical practitioner to recognize a patient with microvascular angina, as the disease has some characteristic presentations, does not respond well to the classical treatments for angina pectoris, and eventually may result in serious complications later.

🔖

Bu Makaleye Atıf Yap

ÖZKAN, H. S., KAYIKÇIOĞLU, M. (2020). PATHOPHYSIOLOGY, CLINICAL FEATURES AND TREATMENT OF MICROVASCULAR ANGINA: A REVIEW. Turkish Medical Student Journal, Cilt: 7 - Sayı: 3, 154–158. https://ajindex.com/articles/809866

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (16)

  1. Gandhi MM, Lampe FC, Wood DA. Incidence, clinical char- acteristics, and short-term prognosis of angina pectoris. Heart 1995;73(2):193-8
  2. Hermann LK, Weingart SD, Yoon YM, et al. Comparison of fre- quency of inducible myocardial ischemia in patients presenting to emergency department with typical versus atypical or nonanginal chest pain. Am J Cardiol 2010;105(11):1561-4
  3. Baggiano A, Guglielmo M, Muscogiuri G et al. (Epicardial and microvascular) angina or atypical chest pain: differential diag- noses with cardiovascular magnetic resonance. Eur Hear J Suppl 2020;22:116-30
  4. Park JJ, Park SJ, Choi DJ. Microvascular angina: Angina that pre- dominantly affects women. Korean J Intern Med 2015;30(2):140-7
  5. Bøtker HE, Sonne HS, Sørensen KE. Frequency of systemic mi- crovascular dysfunction in syndrome x and in variant angina. Am J Cardiol 1996;78(2):182-6
  6. Dessalvi CC, Deidda M, Giorgi M et al. Vascular damage – coro- nary artery disease. J Cardiovasc Echogr 2020;30:11-6
  7. Algranati D, Kassab GS, Lanir Y. Why is the subendocardium more vulnerable to ischemia? A new paradigm. Am J Physiol - Hear Circ Physiol 2011;300(3):1090-100
  8. Kayikcioglu M, Payzin S, Yavuzgil O et al. Benefits of statin treat- ment in cardiac syndrome-X1. Eur Heart J 2003;24(22):1999-2005
  9. Ford TJ, Corcoran D, Berry C. Stable coronary syndromes: Pathophysiology, diagnostic advances and therapeutic need. Heart 2018;104(4):284-92
  10. Lanza GA, De Vita A, Kaski JC. “Primary” microvascular angi- na: clinical characteristics, pathogenesis and management. Interv Cardiol Rev 2018;13(3):108-11
  11. Alroy S, Preis M, Barzilai M et al. Endothelial cell dysfunction in women with cardiac syndrome X and MTHFR C677T mutation. Isr Med Assoc J 2007;9(4):321-5
  12. Seery JP. Therapeutic approach to microvascular angina (syn- drome x). J Am Coll Cardiol 1995;25(6):1472
  13. O’Rourke MF, Nichols WW. Microvascular angina or “vis a ter- go.” J Am Coll Cardiol 2010;55(6):611
  14. Gould KL, Johnson NP. Coronary physiology beyond coronary flow reserve in microvascular angina: jacc state-of-the-art review. J Am Coll Cardiol 2018;72(21):2642-62
  15. Kaski JC, Russo G. Cardiac syndrome X: an overview. Hosp Pract 2000;35(2):75-94
  16. Khera R, Secemsky E, Wang Y et al. Revascularization prac- tices and outcomes in patients with multivessel coronary ar- tery disease who presented with acute myocardial infarction and cardiogenic shock in the us, 2009-2018. JAMA Intern Med 2020;180(10):1317-27. 17.